Deseret Mutual Benefit Administrators’s Vertex Pharmaceuticals VRTX Stock Holding History

Deseret Mutual Benefit Administrators's VRTX Position: Q2 2026 in Review

Deseret Mutual Benefit Administrators reduced its Vertex Pharmaceuticals (VRTX) stake by 2.9% in Q2 2026, selling an estimated $4.43K and leaving 332 shares worth $165K. The position accounts for 0.05% of the portfolio, ranked #224.

Deseret Mutual Benefit Administrators first reported a position in VRTX in Q2 2021 and has held it in 21 quarters since. The position peaked at $180K in Q4 2025. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

• Deseret Mutual Benefit Administrators held 332 shares of Vertex Pharmaceuticals worth $165K as of Q2 2026.
• Deseret Mutual Benefit Administrators sold 10 Vertex Pharmaceuticals shares in Q2 2026, an estimated $4.43K.
• Vertex Pharmaceuticals made up 0.05% of Deseret Mutual Benefit Administrators's portfolio in Q2 2026, its #224 holding.
• Deseret Mutual Benefit Administrators first reported a position in Vertex Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
• Deseret Mutual Benefit Administrators's Vertex Pharmaceuticals position peaked at $180K in Q4 2025.
• 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Deseret Mutual Benefit Administrators's 13F filing for Q2 2026, filed 14 Aug 2026.